nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Teniposide—lymphatic system cancer	0.469	0.588	CbGbCtD
Dexrazoxane—TOP2A—Mitoxantrone—lymphatic system cancer	0.328	0.412	CbGbCtD
Dexrazoxane—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.00133	0.195	CbGdCrCtD
Dexrazoxane—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.00102	0.149	CbGdCrCtD
Dexrazoxane—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000959	0.14	CbGdCrCtD
Dexrazoxane—Hyponatraemia—Vincristine—lymphatic system cancer	0.000673	0.00343	CcSEcCtD
Dexrazoxane—Leukopenia—Teniposide—lymphatic system cancer	0.000672	0.00343	CcSEcCtD
Dexrazoxane—Alopecia—Fludarabine—lymphatic system cancer	0.00067	0.00342	CcSEcCtD
Dexrazoxane—Malnutrition—Fludarabine—lymphatic system cancer	0.00066	0.00337	CcSEcCtD
Dexrazoxane—Pancytopenia—Bleomycin—lymphatic system cancer	0.00066	0.00337	CcSEcCtD
Dexrazoxane—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.000655	0.00334	CcSEcCtD
Dexrazoxane—Weight decreased—Bleomycin—lymphatic system cancer	0.000629	0.00321	CcSEcCtD
Dexrazoxane—Pneumonia—Bleomycin—lymphatic system cancer	0.000623	0.00318	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000613	0.00313	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.000611	0.00312	CcSEcCtD
Dexrazoxane—Anaemia—Fludarabine—lymphatic system cancer	0.00061	0.00311	CcSEcCtD
Dexrazoxane—Infection—Teniposide—lymphatic system cancer	0.000609	0.00311	CcSEcCtD
Dexrazoxane—Dysphagia—Carmustine—lymphatic system cancer	0.000606	0.00309	CcSEcCtD
Dexrazoxane—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000605	0.0884	CbGdCrCtD
Dexrazoxane—Stomatitis—Bleomycin—lymphatic system cancer	0.000604	0.00308	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.000603	0.00308	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0006	0.00306	CcSEcCtD
Dexrazoxane—Malaise—Fludarabine—lymphatic system cancer	0.000595	0.00304	CcSEcCtD
Dexrazoxane—Leukopenia—Fludarabine—lymphatic system cancer	0.000591	0.00302	CcSEcCtD
Dexrazoxane—Pruritus—Mechlorethamine—lymphatic system cancer	0.000588	0.003	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000587	0.003	CcSEcCtD
Dexrazoxane—Anorexia—Teniposide—lymphatic system cancer	0.000584	0.00298	CcSEcCtD
Dexrazoxane—Cough—Fludarabine—lymphatic system cancer	0.000576	0.00294	CcSEcCtD
Dexrazoxane—Pancytopenia—Carmustine—lymphatic system cancer	0.000576	0.00294	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000575	0.00294	CcSEcCtD
Dexrazoxane—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000569	0.0029	CcSEcCtD
Dexrazoxane—Neutropenia—Carmustine—lymphatic system cancer	0.000567	0.00289	CcSEcCtD
Dexrazoxane—Myalgia—Fludarabine—lymphatic system cancer	0.000562	0.00287	CcSEcCtD
Dexrazoxane—Haemoglobin—Bleomycin—lymphatic system cancer	0.000559	0.00285	CcSEcCtD
Dexrazoxane—Haemorrhage—Bleomycin—lymphatic system cancer	0.000556	0.00284	CcSEcCtD
Dexrazoxane—Discomfort—Fludarabine—lymphatic system cancer	0.000555	0.00283	CcSEcCtD
Dexrazoxane—Pancytopenia—Vincristine—lymphatic system cancer	0.00055	0.0028	CcSEcCtD
Dexrazoxane—Dyspnoea—Teniposide—lymphatic system cancer	0.000547	0.00279	CcSEcCtD
Dexrazoxane—Pneumonia—Carmustine—lymphatic system cancer	0.000544	0.00277	CcSEcCtD
Dexrazoxane—Neutropenia—Vincristine—lymphatic system cancer	0.000541	0.00276	CcSEcCtD
Dexrazoxane—Depression—Carmustine—lymphatic system cancer	0.000539	0.00275	CcSEcCtD
Dexrazoxane—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000535	0.00273	CcSEcCtD
Dexrazoxane—Infection—Fludarabine—lymphatic system cancer	0.000535	0.00273	CcSEcCtD
Dexrazoxane—Decreased appetite—Teniposide—lymphatic system cancer	0.000533	0.00272	CcSEcCtD
Dexrazoxane—Vomiting—Mechlorethamine—lymphatic system cancer	0.000529	0.0027	CcSEcCtD
Dexrazoxane—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000528	0.0027	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000528	0.00269	CcSEcCtD
Dexrazoxane—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000527	0.00269	CcSEcCtD
Dexrazoxane—Stomatitis—Carmustine—lymphatic system cancer	0.000527	0.00269	CcSEcCtD
Dexrazoxane—Weight decreased—Vincristine—lymphatic system cancer	0.000524	0.00267	CcSEcCtD
Dexrazoxane—Pneumonia—Vincristine—lymphatic system cancer	0.000519	0.00265	CcSEcCtD
Dexrazoxane—Depression—Vincristine—lymphatic system cancer	0.000515	0.00263	CcSEcCtD
Dexrazoxane—Anorexia—Fludarabine—lymphatic system cancer	0.000514	0.00262	CcSEcCtD
Dexrazoxane—Extravasation—Methotrexate—lymphatic system cancer	0.000513	0.00262	CcSEcCtD
Dexrazoxane—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00051	0.0026	CcSEcCtD
Dexrazoxane—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000506	0.00258	CcSEcCtD
Dexrazoxane—Feeling abnormal—Teniposide—lymphatic system cancer	0.000505	0.00258	CcSEcCtD
Dexrazoxane—Stomatitis—Vincristine—lymphatic system cancer	0.000503	0.00257	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000501	0.00256	CcSEcCtD
Dexrazoxane—Nausea—Mechlorethamine—lymphatic system cancer	0.000494	0.00252	CcSEcCtD
Dexrazoxane—Alopecia—Bleomycin—lymphatic system cancer	0.000491	0.00251	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000491	0.0025	CcSEcCtD
Dexrazoxane—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00049	0.0025	CcSEcCtD
Dexrazoxane—Haemoglobin—Carmustine—lymphatic system cancer	0.000488	0.00249	CcSEcCtD
Dexrazoxane—Urticaria—Teniposide—lymphatic system cancer	0.000487	0.00248	CcSEcCtD
Dexrazoxane—Haemorrhage—Carmustine—lymphatic system cancer	0.000485	0.00248	CcSEcCtD
Dexrazoxane—Abdominal pain—Teniposide—lymphatic system cancer	0.000485	0.00247	CcSEcCtD
Dexrazoxane—Body temperature increased—Teniposide—lymphatic system cancer	0.000485	0.00247	CcSEcCtD
Dexrazoxane—Erythema—Bleomycin—lymphatic system cancer	0.000484	0.00247	CcSEcCtD
Dexrazoxane—Dyspnoea—Fludarabine—lymphatic system cancer	0.00048	0.00245	CcSEcCtD
Dexrazoxane—Oedema peripheral—Carmustine—lymphatic system cancer	0.000478	0.00244	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000477	0.00243	CcSEcCtD
Dexrazoxane—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000469	0.00239	CcSEcCtD
Dexrazoxane—Decreased appetite—Fludarabine—lymphatic system cancer	0.000468	0.00239	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000465	0.00237	CcSEcCtD
Dexrazoxane—Fatigue—Fludarabine—lymphatic system cancer	0.000465	0.00237	CcSEcCtD
Dexrazoxane—Constipation—Fludarabine—lymphatic system cancer	0.000461	0.00235	CcSEcCtD
Dexrazoxane—Pain—Fludarabine—lymphatic system cancer	0.000461	0.00235	CcSEcCtD
Dexrazoxane—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000458	0.0669	CbGdCrCtD
Dexrazoxane—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000455	0.00232	CcSEcCtD
Dexrazoxane—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000454	0.00231	CcSEcCtD
Dexrazoxane—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000451	0.0023	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000449	0.00229	CcSEcCtD
Dexrazoxane—Anaemia—Bleomycin—lymphatic system cancer	0.000447	0.00228	CcSEcCtD
Dexrazoxane—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000444	0.00227	CcSEcCtD
Dexrazoxane—Asthenia—Teniposide—lymphatic system cancer	0.00044	0.00224	CcSEcCtD
Dexrazoxane—Malaise—Bleomycin—lymphatic system cancer	0.000437	0.00223	CcSEcCtD
Dexrazoxane—Pruritus—Teniposide—lymphatic system cancer	0.000434	0.00221	CcSEcCtD
Dexrazoxane—Leukopenia—Bleomycin—lymphatic system cancer	0.000433	0.00221	CcSEcCtD
Dexrazoxane—Cardiac disorder—Vincristine—lymphatic system cancer	0.00043	0.00219	CcSEcCtD
Dexrazoxane—Alopecia—Carmustine—lymphatic system cancer	0.000429	0.00219	CcSEcCtD
Dexrazoxane—Body temperature increased—Fludarabine—lymphatic system cancer	0.000426	0.00217	CcSEcCtD
Dexrazoxane—Mental disorder—Carmustine—lymphatic system cancer	0.000425	0.00217	CcSEcCtD
Dexrazoxane—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000423	0.0619	CbGdCrCtD
Dexrazoxane—Erythema—Carmustine—lymphatic system cancer	0.000423	0.00216	CcSEcCtD
Dexrazoxane—Malnutrition—Carmustine—lymphatic system cancer	0.000423	0.00216	CcSEcCtD
Dexrazoxane—Cough—Bleomycin—lymphatic system cancer	0.000422	0.00216	CcSEcCtD
Dexrazoxane—Angiopathy—Vincristine—lymphatic system cancer	0.00042	0.00214	CcSEcCtD
Dexrazoxane—Diarrhoea—Teniposide—lymphatic system cancer	0.000419	0.00214	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000418	0.00213	CcSEcCtD
Dexrazoxane—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000416	0.0608	CbGdCrCtD
Dexrazoxane—Myalgia—Bleomycin—lymphatic system cancer	0.000412	0.0021	CcSEcCtD
Dexrazoxane—Alopecia—Vincristine—lymphatic system cancer	0.000409	0.00209	CcSEcCtD
Dexrazoxane—Discomfort—Bleomycin—lymphatic system cancer	0.000407	0.00208	CcSEcCtD
Dexrazoxane—Mental disorder—Vincristine—lymphatic system cancer	0.000406	0.00207	CcSEcCtD
Dexrazoxane—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.0004	0.0584	CbGdCrCtD
Dexrazoxane—Alopecia—Mitoxantrone—lymphatic system cancer	0.000399	0.00203	CcSEcCtD
Dexrazoxane—Tremor—Carmustine—lymphatic system cancer	0.000396	0.00202	CcSEcCtD
Dexrazoxane—Erythema—Mitoxantrone—lymphatic system cancer	0.000393	0.002	CcSEcCtD
Dexrazoxane—Infection—Bleomycin—lymphatic system cancer	0.000393	0.002	CcSEcCtD
Dexrazoxane—Anaemia—Carmustine—lymphatic system cancer	0.000391	0.00199	CcSEcCtD
Dexrazoxane—Vomiting—Teniposide—lymphatic system cancer	0.00039	0.00199	CcSEcCtD
Dexrazoxane—Sepsis—Methotrexate—lymphatic system cancer	0.000389	0.00198	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000387	0.00197	CcSEcCtD
Dexrazoxane—Asthenia—Fludarabine—lymphatic system cancer	0.000387	0.00197	CcSEcCtD
Dexrazoxane—Headache—Teniposide—lymphatic system cancer	0.000384	0.00196	CcSEcCtD
Dexrazoxane—Pruritus—Fludarabine—lymphatic system cancer	0.000381	0.00194	CcSEcCtD
Dexrazoxane—Leukopenia—Carmustine—lymphatic system cancer	0.000378	0.00193	CcSEcCtD
Dexrazoxane—Anorexia—Bleomycin—lymphatic system cancer	0.000377	0.00192	CcSEcCtD
Dexrazoxane—Anaemia—Vincristine—lymphatic system cancer	0.000373	0.0019	CcSEcCtD
Dexrazoxane—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.00037	0.0541	CbGdCrCtD
Dexrazoxane—Diarrhoea—Fludarabine—lymphatic system cancer	0.000369	0.00188	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000364	0.00186	CcSEcCtD
Dexrazoxane—Nausea—Teniposide—lymphatic system cancer	0.000364	0.00186	CcSEcCtD
Dexrazoxane—Anaemia—Mitoxantrone—lymphatic system cancer	0.000363	0.00185	CcSEcCtD
Dexrazoxane—Leukopenia—Vincristine—lymphatic system cancer	0.000361	0.00184	CcSEcCtD
Dexrazoxane—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.00036	0.0526	CbGdCrCtD
Dexrazoxane—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00036	0.00184	CcSEcCtD
Dexrazoxane—Myalgia—Carmustine—lymphatic system cancer	0.00036	0.00184	CcSEcCtD
Dexrazoxane—Malaise—Mitoxantrone—lymphatic system cancer	0.000354	0.00181	CcSEcCtD
Dexrazoxane—Dyspnoea—Bleomycin—lymphatic system cancer	0.000352	0.0018	CcSEcCtD
Dexrazoxane—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000352	0.00179	CcSEcCtD
Dexrazoxane—Decreased appetite—Bleomycin—lymphatic system cancer	0.000343	0.00175	CcSEcCtD
Dexrazoxane—Myalgia—Vincristine—lymphatic system cancer	0.000343	0.00175	CcSEcCtD
Dexrazoxane—Cough—Mitoxantrone—lymphatic system cancer	0.000343	0.00175	CcSEcCtD
Dexrazoxane—Infection—Carmustine—lymphatic system cancer	0.000343	0.00175	CcSEcCtD
Dexrazoxane—Vomiting—Fludarabine—lymphatic system cancer	0.000343	0.00175	CcSEcCtD
Dexrazoxane—Pain—Bleomycin—lymphatic system cancer	0.000338	0.00172	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000338	0.00172	CcSEcCtD
Dexrazoxane—Headache—Fludarabine—lymphatic system cancer	0.000338	0.00172	CcSEcCtD
Dexrazoxane—Myalgia—Mitoxantrone—lymphatic system cancer	0.000334	0.00171	CcSEcCtD
Dexrazoxane—Discomfort—Mitoxantrone—lymphatic system cancer	0.00033	0.00169	CcSEcCtD
Dexrazoxane—Anorexia—Carmustine—lymphatic system cancer	0.000329	0.00168	CcSEcCtD
Dexrazoxane—Infection—Vincristine—lymphatic system cancer	0.000327	0.00167	CcSEcCtD
Dexrazoxane—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000326	0.00166	CcSEcCtD
Dexrazoxane—Nervous system disorder—Vincristine—lymphatic system cancer	0.000323	0.00165	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000322	0.00164	CcSEcCtD
Dexrazoxane—Nausea—Fludarabine—lymphatic system cancer	0.00032	0.00163	CcSEcCtD
Dexrazoxane—Infection—Mitoxantrone—lymphatic system cancer	0.000319	0.00162	CcSEcCtD
Dexrazoxane—Shock—Mitoxantrone—lymphatic system cancer	0.000315	0.00161	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000314	0.0016	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000314	0.0016	CcSEcCtD
Dexrazoxane—Urticaria—Bleomycin—lymphatic system cancer	0.000314	0.0016	CcSEcCtD
Dexrazoxane—Anorexia—Vincristine—lymphatic system cancer	0.000314	0.0016	CcSEcCtD
Dexrazoxane—Body temperature increased—Bleomycin—lymphatic system cancer	0.000312	0.00159	CcSEcCtD
Dexrazoxane—Insomnia—Carmustine—lymphatic system cancer	0.000312	0.00159	CcSEcCtD
Dexrazoxane—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000311	0.00159	CcSEcCtD
Dexrazoxane—Dyspnoea—Carmustine—lymphatic system cancer	0.000307	0.00157	CcSEcCtD
Dexrazoxane—Somnolence—Carmustine—lymphatic system cancer	0.000307	0.00156	CcSEcCtD
Dexrazoxane—Anorexia—Mitoxantrone—lymphatic system cancer	0.000306	0.00156	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0003	0.00153	CcSEcCtD
Dexrazoxane—Decreased appetite—Carmustine—lymphatic system cancer	0.0003	0.00153	CcSEcCtD
Dexrazoxane—Insomnia—Vincristine—lymphatic system cancer	0.000298	0.00152	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000298	0.00152	CcSEcCtD
Dexrazoxane—Constipation—Carmustine—lymphatic system cancer	0.000295	0.0015	CcSEcCtD
Dexrazoxane—Pain—Carmustine—lymphatic system cancer	0.000295	0.0015	CcSEcCtD
Dexrazoxane—Breast disorder—Methotrexate—lymphatic system cancer	0.000294	0.0015	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000292	0.00149	CcSEcCtD
Dexrazoxane—Decreased appetite—Vincristine—lymphatic system cancer	0.000286	0.00146	CcSEcCtD
Dexrazoxane—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000286	0.00146	CcSEcCtD
Dexrazoxane—Somnolence—Mitoxantrone—lymphatic system cancer	0.000285	0.00145	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000284	0.00145	CcSEcCtD
Dexrazoxane—Feeling abnormal—Carmustine—lymphatic system cancer	0.000284	0.00145	CcSEcCtD
Dexrazoxane—Fatigue—Vincristine—lymphatic system cancer	0.000284	0.00145	CcSEcCtD
Dexrazoxane—Asthenia—Bleomycin—lymphatic system cancer	0.000283	0.00145	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000282	0.00144	CcSEcCtD
Dexrazoxane—Pain—Vincristine—lymphatic system cancer	0.000282	0.00144	CcSEcCtD
Dexrazoxane—Constipation—Vincristine—lymphatic system cancer	0.000282	0.00144	CcSEcCtD
Dexrazoxane—Pruritus—Bleomycin—lymphatic system cancer	0.00028	0.00143	CcSEcCtD
Dexrazoxane—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000279	0.00142	CcSEcCtD
Dexrazoxane—Fatigue—Mitoxantrone—lymphatic system cancer	0.000276	0.00141	CcSEcCtD
Dexrazoxane—Constipation—Mitoxantrone—lymphatic system cancer	0.000274	0.0014	CcSEcCtD
Dexrazoxane—Pain—Mitoxantrone—lymphatic system cancer	0.000274	0.0014	CcSEcCtD
Dexrazoxane—Abdominal pain—Carmustine—lymphatic system cancer	0.000273	0.00139	CcSEcCtD
Dexrazoxane—Body temperature increased—Carmustine—lymphatic system cancer	0.000273	0.00139	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000269	0.00137	CcSEcCtD
Dexrazoxane—Pancytopenia—Methotrexate—lymphatic system cancer	0.000267	0.00136	CcSEcCtD
Dexrazoxane—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000264	0.00135	CcSEcCtD
Dexrazoxane—Neutropenia—Methotrexate—lymphatic system cancer	0.000263	0.00134	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000262	0.00134	CcSEcCtD
Dexrazoxane—Body temperature increased—Vincristine—lymphatic system cancer	0.00026	0.00133	CcSEcCtD
Dexrazoxane—Abdominal pain—Vincristine—lymphatic system cancer	0.00026	0.00133	CcSEcCtD
Dexrazoxane—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000258	0.0377	CbGdCrCtD
Dexrazoxane—Urticaria—Mitoxantrone—lymphatic system cancer	0.000255	0.0013	CcSEcCtD
Dexrazoxane—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000253	0.00129	CcSEcCtD
Dexrazoxane—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000253	0.00129	CcSEcCtD
Dexrazoxane—Pneumonia—Methotrexate—lymphatic system cancer	0.000252	0.00129	CcSEcCtD
Dexrazoxane—Vomiting—Bleomycin—lymphatic system cancer	0.000251	0.00128	CcSEcCtD
Dexrazoxane—Infestation NOS—Methotrexate—lymphatic system cancer	0.00025	0.00128	CcSEcCtD
Dexrazoxane—Infestation—Methotrexate—lymphatic system cancer	0.00025	0.00128	CcSEcCtD
Dexrazoxane—Depression—Methotrexate—lymphatic system cancer	0.00025	0.00127	CcSEcCtD
Dexrazoxane—Asthenia—Carmustine—lymphatic system cancer	0.000247	0.00126	CcSEcCtD
Dexrazoxane—Stomatitis—Methotrexate—lymphatic system cancer	0.000244	0.00125	CcSEcCtD
Dexrazoxane—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000244	0.0356	CbGdCrCtD
Dexrazoxane—Asthenia—Vincristine—lymphatic system cancer	0.000236	0.0012	CcSEcCtD
Dexrazoxane—Diarrhoea—Carmustine—lymphatic system cancer	0.000236	0.0012	CcSEcCtD
Dexrazoxane—Nausea—Bleomycin—lymphatic system cancer	0.000235	0.0012	CcSEcCtD
Dexrazoxane—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000234	0.00119	CcSEcCtD
Dexrazoxane—Asthenia—Mitoxantrone—lymphatic system cancer	0.00023	0.00117	CcSEcCtD
Dexrazoxane—Dizziness—Carmustine—lymphatic system cancer	0.000228	0.00116	CcSEcCtD
Dexrazoxane—Haemoglobin—Methotrexate—lymphatic system cancer	0.000226	0.00115	CcSEcCtD
Dexrazoxane—Diarrhoea—Vincristine—lymphatic system cancer	0.000225	0.00115	CcSEcCtD
Dexrazoxane—Haemorrhage—Methotrexate—lymphatic system cancer	0.000225	0.00115	CcSEcCtD
Dexrazoxane—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000219	0.00112	CcSEcCtD
Dexrazoxane—Vomiting—Carmustine—lymphatic system cancer	0.000219	0.00112	CcSEcCtD
Dexrazoxane—Dizziness—Vincristine—lymphatic system cancer	0.000218	0.00111	CcSEcCtD
Dexrazoxane—Headache—Carmustine—lymphatic system cancer	0.000216	0.0011	CcSEcCtD
Dexrazoxane—Vomiting—Vincristine—lymphatic system cancer	0.000209	0.00107	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000209	0.00106	CcSEcCtD
Dexrazoxane—Headache—Vincristine—lymphatic system cancer	0.000206	0.00105	CcSEcCtD
Dexrazoxane—Nausea—Carmustine—lymphatic system cancer	0.000205	0.00105	CcSEcCtD
Dexrazoxane—Angiopathy—Methotrexate—lymphatic system cancer	0.000204	0.00104	CcSEcCtD
Dexrazoxane—Vomiting—Mitoxantrone—lymphatic system cancer	0.000204	0.00104	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000203	0.00103	CcSEcCtD
Dexrazoxane—Headache—Mitoxantrone—lymphatic system cancer	0.000201	0.00102	CcSEcCtD
Dexrazoxane—Alopecia—Methotrexate—lymphatic system cancer	0.000199	0.00101	CcSEcCtD
Dexrazoxane—Mental disorder—Methotrexate—lymphatic system cancer	0.000197	0.001	CcSEcCtD
Dexrazoxane—Malnutrition—Methotrexate—lymphatic system cancer	0.000196	0.000999	CcSEcCtD
Dexrazoxane—Erythema—Methotrexate—lymphatic system cancer	0.000196	0.000999	CcSEcCtD
Dexrazoxane—Nausea—Vincristine—lymphatic system cancer	0.000196	0.000998	CcSEcCtD
Dexrazoxane—Nausea—Mitoxantrone—lymphatic system cancer	0.00019	0.000972	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000182	0.000926	CcSEcCtD
Dexrazoxane—Anaemia—Methotrexate—lymphatic system cancer	0.000181	0.000923	CcSEcCtD
Dexrazoxane—Malaise—Methotrexate—lymphatic system cancer	0.000177	0.0009	CcSEcCtD
Dexrazoxane—Leukopenia—Methotrexate—lymphatic system cancer	0.000175	0.000894	CcSEcCtD
Dexrazoxane—Cough—Methotrexate—lymphatic system cancer	0.000171	0.000871	CcSEcCtD
Dexrazoxane—Myalgia—Methotrexate—lymphatic system cancer	0.000167	0.00085	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000165	0.000844	CcSEcCtD
Dexrazoxane—Discomfort—Methotrexate—lymphatic system cancer	0.000165	0.00084	CcSEcCtD
Dexrazoxane—Infection—Methotrexate—lymphatic system cancer	0.000159	0.00081	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000157	0.000799	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000156	0.000798	CcSEcCtD
Dexrazoxane—Skin disorder—Methotrexate—lymphatic system cancer	0.000155	0.000792	CcSEcCtD
Dexrazoxane—Anorexia—Methotrexate—lymphatic system cancer	0.000152	0.000777	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000146	0.000742	CcSEcCtD
Dexrazoxane—Insomnia—Methotrexate—lymphatic system cancer	0.000144	0.000737	CcSEcCtD
Dexrazoxane—Dyspnoea—Methotrexate—lymphatic system cancer	0.000142	0.000727	CcSEcCtD
Dexrazoxane—Somnolence—Methotrexate—lymphatic system cancer	0.000142	0.000724	CcSEcCtD
Dexrazoxane—Decreased appetite—Methotrexate—lymphatic system cancer	0.000139	0.000708	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000138	0.000704	CcSEcCtD
Dexrazoxane—Fatigue—Methotrexate—lymphatic system cancer	0.000138	0.000703	CcSEcCtD
Dexrazoxane—Pain—Methotrexate—lymphatic system cancer	0.000137	0.000697	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000132	0.000672	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000131	0.000666	CcSEcCtD
Dexrazoxane—Urticaria—Methotrexate—lymphatic system cancer	0.000127	0.000647	CcSEcCtD
Dexrazoxane—Abdominal pain—Methotrexate—lymphatic system cancer	0.000126	0.000644	CcSEcCtD
Dexrazoxane—Body temperature increased—Methotrexate—lymphatic system cancer	0.000126	0.000644	CcSEcCtD
Dexrazoxane—Asthenia—Methotrexate—lymphatic system cancer	0.000115	0.000585	CcSEcCtD
Dexrazoxane—Pruritus—Methotrexate—lymphatic system cancer	0.000113	0.000577	CcSEcCtD
Dexrazoxane—Diarrhoea—Methotrexate—lymphatic system cancer	0.000109	0.000558	CcSEcCtD
Dexrazoxane—Dizziness—Methotrexate—lymphatic system cancer	0.000106	0.000539	CcSEcCtD
Dexrazoxane—Vomiting—Methotrexate—lymphatic system cancer	0.000102	0.000518	CcSEcCtD
Dexrazoxane—Headache—Methotrexate—lymphatic system cancer	0.0001	0.000511	CcSEcCtD
Dexrazoxane—Nausea—Methotrexate—lymphatic system cancer	9.49e-05	0.000484	CcSEcCtD
